The competition between Novo Nordisk and Eli Lilly over the most effective obesity pill is intensifying. While NovoNordisk led with injectable drugs Ozempic and Wegovy, Eli Lilly’s injectables Mounjaro and Zepbound have recently taken a dominant position; the race now focuses on oral options. #NovoNordisk #EliLilly #FiatNews